EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Clinical and Laboratory Predictors of Intensive Care Unit Admission in Romanian Measles Cases: A Retrospective Cohort Analysis (2023–2025)

Aneta-Rada Dobrin, Tamara Mirela Porosnicu iD, Islam Ragab, Lucian-Flavius Herlo, Voichita Elena Lazureanu, Alexandra Herlo, Felix Bratosin iD, Cristian Iulian Oancea, Silvia Alda, Monica Licker iD

Viruses · 2025

DOI: 10.3390/v17081119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Aneta-Rada Dobrin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania. Hauptthemen laut MEDLINE: Measles, Intensive Care Units, Patient Admission. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victor Babes University of Medicine and Pharmacy, Timișoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Romania has experienced the highest measles incidence rate in the European Union since late 2023, driven by suboptimal measles–mumps–rubella (MMR) uptake. Contemporary data on bedside predictors of clinical deterioration are scarce. The objective was to characterise demographic, clinical and laboratory differences between severe and non-severe measles and derive a multivariable model for intensive-care-unit (ICU) admission.

Methods

We undertook a retrospective cohort study at the “Victor Babeș” University Hospital for Infectious Diseases, Timișoara. All admissions from 1 November 2023 to 15 May 2025 with serological or RT-PCR confirmation and a complete baseline laboratory panel were included. Descriptive statistics compared ward-managed versus ICU-managed patients; independent predictors of ICU transfer were identified through logistic regression that incorporated age, vaccination status, leukocyte count, C-reactive protein (CRP) and interleukin-6 (IL-6).

Results

Among 455 patients (median age 3.0 y, interquartile range [IQR] 1.0–7.0), 17 (3.7%) required ICU care. Vaccine coverage was 18.0% overall and 0% among ICU cases. Compared with ward peers, ICU patients exhibited higher leukocyte counts (8.1 × 109 L vs. 6.0 × 109 L; p = 0.003) and a near-five-fold elevation in IL-6 (18 pg mL vs. 4 pg mL; p < 0.001), while CRP, procalcitonin and fibrinogen were similar. ICU admission prolonged median length of stay from 5 days (IQR 4–7) to 8 days (5–12; p = 0.004). In multivariable modelling, IL-6 remained the sole independent predictor (odds ratio [OR] 1.07 per pg mL; 95% confidence interval [CI] 1.03–1.12; p = 0.001); the model’s AUC was 0.83, indicating good discrimination. Complete separation precluded reliable estimation of the protective effect of vaccination, but no vaccinated child required ICU care.

Conclusions

A simple admission panel centred on IL-6 accurately identified Romanian measles patients at risk of critical deterioration, whereas traditional markers such as CRP and leukocyte count added little incremental value. Even a single documented MMR dose was associated with the complete absence of ICU transfers, underscoring the urgent need for catch-up immunisation campaigns. Integrating IL-6-guided triage with intensified vaccination outreach could substantially reduce measles-related morbidity and health-system strain in low-coverage EU settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeaslesIntensive Care UnitsPatient AdmissionHumansRetrospective StudiesMaleFemaleRomaniaChild, PreschoolInfantChildC-Reactive ProteinHospitalizationInterleukin-6IncidenceVaccination

Stichwörter der Autor:innen

C-reactive proteinRomaniaintensive care unitsmeaslesvaccination

Substanzen

C-Reactive ProteinInterleukin-6

Autor:innen und Institutionen

  • Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
  • Anaesthesia and Intensive Care Research Center, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Faculty of Medicine, Misr University for Science & Technology, 6th of October 3237101, Egypt.
  • Department XIII, Discipline of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
  • Department XIII, Discipline of Pulmonology, Victor Babes University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
  • Center for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), Victor Babes University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.

ORCID-Profile: Tamara Mirela Porosnicu, Felix Bratosin, Monica Licker

Förderung

  • Victor Babes University of Medicine and Pharmacy, Timișoara

Zitieren

APA

Dobrin, A. R., Porosnicu, T. M., Ragab, I., Herlo, L. F., Lazureanu, V. E., Herlo, A., Bratosin, F., Oancea, C. I., Alda, S., & Licker, M. (2025). The Clinical and Laboratory Predictors of Intensive Care Unit Admission in Romanian Measles Cases: A Retrospective Cohort Analysis (2023–2025). Viruses. https://doi.org/10.3390/v17081119

Vancouver

Dobrin AR, Porosnicu TM, Ragab I, Herlo LF, Lazureanu VE, Herlo A, et al. The Clinical and Laboratory Predictors of Intensive Care Unit Admission in Romanian Measles Cases: A Retrospective Cohort Analysis (2023–2025). Viruses. 2025. doi:10.3390/v17081119

BibTeX
@article{Dobrin2025,
  author = {Dobrin, Aneta-Rada and Porosnicu, Tamara Mirela and Ragab, Islam and Herlo, Lucian-Flavius and Lazureanu, Voichita Elena and Herlo, Alexandra and Bratosin, Felix and Oancea, Cristian Iulian and Alda, Silvia and Licker, Monica},
  title = {The Clinical and Laboratory Predictors of Intensive Care Unit Admission in Romanian Measles Cases: A Retrospective Cohort Analysis (2023–2025)},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17081119}
}
Kostenlos starten →